Join to View Full Profile
701 Ostrum StSte 501Fountain Hill, PA 18015
Phone+1 484-503-7000
Fax+1 484-503-7001
Dr. Albandar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Heidar Albandar, MD is an oncologist located in Fountain Hill, PA. He completed his medical education in 2015 at Lewis Katz School of Medicine at Temple University. He also has numerous publications related to oncology under his belt, including research on aspirin use and immunotherapy outcomes, immune-related adverse events, smoking's association with adrenal adenomas and adrenocortical carcinomas, and aspirin use and mortality in colorectal cancer. His works have been widely cited by other publications.
Education & Training
West Virginia UniversityFellowship, Hematology and Medical Oncology, 2018 - 2021
Wright State UniversityResidency, Internal Medicine, 2016 - 2018- Wright State UniversityInternship, Internal Medicine, 2015 - 2016
Lewis Katz School of Medicine at Temple UniversityClass of 2015
Certifications & Licensure
NJ State Medical License 2022 - 2027
PA State Medical License 2021 - 2026
HI State Medical License 2023 - 2024
MD State Medical License 2023 - 2024
WV State Medical License 2018 - 2024
OH State Medical License 2015 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Quantitative peripheral live single T-cell dynamic polyfunctionality profiling predicts lung cancer checkpoint immunotherapy treatment response and clinical outcomes.Zuan-Fu Lim, Xiaoliang Wu, Lin Zhu, Heidar Albandar, Maria Hafez
Translational Lung Cancer Research. 2024-12-31 - 8 citationsDoes the Combined Use of Aspirin and Immunotherapy Result in Better Outcomes in Non-Small Cell Lung Cancer Than Immunotherapy Alone?Mina Aiad, Ali Tahir, Kayla Fresco, Zarian Prenatt, Karla Ramos-Feliciano
Cureus. 2022-06-01 - 37 citationsImmune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?Heidar Albandar, Jacob Fuqua, Jasim M. Albandar, Salahuddin Safi, Samuel A. Merrill
Cancers. 2021-02-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
